Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Aikang Biomedical Co., Ltd. is a prominent Chinese medical technology company specializing in the research, development, and manufacturing of In Vitro Diagnostic (IVD) systems and reagents. Established in 2003, the company provides high-performance automated solutions for clinical laboratories, including fully automated ELISA processors, chemiluminescence immunoassay (CLIA) systems, and sample processing units. Aikang is particularly recognized for its 'Aigel' brand, which leads the market in automated blood grouping analyzers used by hospitals and blood centers globally. The company's comprehensive reagent portfolio supports testing for infectious diseases, tumor markers, and hormonal functions. Headquartered in Shenzhen with extensive manufacturing and R&D facilities, Aikang Biomedical plays a vital role in advancing laboratory automation within the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aikang Biomedical.